"Clinical Trials as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.
| Descriptor ID |
D002986
|
| MeSH Number(s) |
E05.318.760.250.500 N05.715.360.775.088.500 N06.850.520.450.250.250
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Clinical Trials as Topic".
Below are MeSH descriptors whose meaning is more specific than "Clinical Trials as Topic".
This graph shows the total number of publications written about "Clinical Trials as Topic" by people in this website by year, and whether "Clinical Trials as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 |
| 1996 | 0 | 1 | 1 |
| 2001 | 1 | 3 | 4 |
| 2002 | 1 | 4 | 5 |
| 2003 | 2 | 4 | 6 |
| 2004 | 2 | 9 | 11 |
| 2005 | 1 | 5 | 6 |
| 2006 | 3 | 8 | 11 |
| 2007 | 2 | 6 | 8 |
| 2008 | 0 | 5 | 5 |
| 2009 | 1 | 7 | 8 |
| 2010 | 4 | 11 | 15 |
| 2011 | 4 | 6 | 10 |
| 2012 | 2 | 10 | 12 |
| 2013 | 4 | 4 | 8 |
| 2014 | 2 | 7 | 9 |
| 2015 | 2 | 10 | 12 |
| 2016 | 7 | 20 | 27 |
| 2017 | 102 | 245 | 347 |
| 2018 | 82 | 243 | 325 |
| 2019 | 37 | 100 | 137 |
| 2020 | 105 | 173 | 278 |
| 2021 | 39 | 98 | 137 |
To return to the timeline, click here.
Below are the most recent publications written about "Clinical Trials as Topic" by people in Profiles.
-
RNA-Based COVID-19 vaccine candidates with clinical phase trials in progress Turk J Med Sci. 2021 12 17; 51(SI-1):3246-3252.
-
Nucleic acid vaccines and CpG oligodeoxynucleotides for allergen immunotherapy. Curr Opin Allergy Clin Immunol. 2021 12 01; 21(6):569-575.
-
When innovation outpaces regulations: The legal challenges for direct-to-patient supply of investigational medicinal products. Br J Clin Pharmacol. 2022 03; 88(3):1115-1142.
-
Misalignment between COVID-19 hotspots and clinical trial sites. J Am Med Inform Assoc. 2021 10 12; 28(11):2461-2466.
-
COVID-19 vaccines are effective in people with obesity: A position statement from The Obesity Society. Obesity (Silver Spring). 2021 10; 29(10):1575-1579.
-
Restrictions on the use of placebo in new COVID-19 vaccine trials. Eur J Clin Pharmacol. 2022 Jan; 78(1):147-148.
-
SafeFit Trial: virtual clinics to deliver a multimodal intervention to improve psychological and physical well-being in people with cancer. Protocol of a COVID-19 targeted non-randomised phase III trial. BMJ Open. 2021 08 26; 11(8):e048175.
-
Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies. Signal Transduct Target Ther. 2021 08 26; 6(1):317.
-
India and management of COVID-19: A case study on published guidelines. Drug Discov Ther. 2021 Sep 22; 15(4):171-179.
-
Mesenchymal stem cells in SARS-CoV-2 infection: A hype or hope. Life Sci. 2021 Nov 01; 284:119901.